Genomic basis of a polyagglutinating isolate of Neisseria meningitidis

Lavanya Rishishwar1, Lee S Katz, Nitya V Sharma

  • 1School of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA.

Journal of Bacteriology
|August 21, 2012
PubMed

Insights

Genomic analysis revealed a Neisseria meningitidis isolate with a serogroup C background but a serogroup B capsule gene. This capsule-switching event may represent a vaccine escape mutant with public health implications.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Neisseria meningitidis outbreaks are managed using serogroup assays targeting the polysaccharide capsule.
  • Conflicting serogroup assay results for invasive meningococcal disease isolates necessitate genomic investigation.

Purpose of the Study:

  • To determine the genomic basis for discordant serogroup assay results in a Neisseria meningitidis isolate (M16917).
  • To investigate the potential public health implications of capsule-switching events in Neisseria meningitidis.

Main Methods:

  • Whole-genome sequencing and comparative genomic analysis of the M16917 isolate.
  • Multilocus sequence typing (MLST) and phylogenetic analysis.
  • Identification of recombination breakpoints and sequence cassette integration.

Main Results:

  • The M16917 isolate belongs to the ST-11 sequence group, typically associated with serogroup C.
  • The capsule polymerase gene (synD) of M16917 was identified as belonging to serogroup B.
  • Homologous recombination resulted in the insertion of a serogroup B capsule gene cassette into a serogroup C genomic background.

Conclusions:

  • A capsule-switching event, involving homologous recombination, occurred in the M16917 Neisseria meningitidis isolate.
  • This event resulted in a strain with a serogroup B capsule in a serogroup C background.
  • The identified capsule-switching mechanism may lead to vaccine escape mutants, posing a public health concern due to the lack of a serogroup B vaccine.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Fimbriae, Pili, and Axial Filaments01:28

Fimbriae, Pili, and Axial Filaments

Fimbriae and pili are specialized bacterial surface structures that play pivotal roles in adhesion, genetic exchange, and motility. Composed primarily of pilin protein, these hairlike appendages are crucial for bacterial survival and pathogenicity in various environments.Fimbriae: Adhesion and PathogenicityFimbriae are fine, filamentous structures measuring 2–10 nanometers in diameter and are densely distributed on the bacterial cell surface. They facilitate bacterial adhesion to abiotic...